These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12425870)

  • 1. Topical agents and erectile dysfunction: is there a place?
    Yap RL; McVary KT
    Curr Urol Rep; 2002 Dec; 3(6):471-6. PubMed ID: 12425870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal and topical pharmacotherapy for male sexual dysfunction.
    Ohebshalom M; Mulhall JP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
    Chew KK
    Aust Fam Physician; 2001 Jan; 30(1):43-6. PubMed ID: 11211711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical treatment of erectile dysfunction. Possibilities and perspectives].
    Pastorini S; Cocimano V; Pugno E; Marten Perolino R
    Arch Ital Urol Androl; 1995 Dec; 67(5):299-302. PubMed ID: 8589743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for erectile dysfunction.
    Lue TF; Lee KL
    Chin Med J (Engl); 2000 Apr; 113(4):291-8. PubMed ID: 11775221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Our experience with pharmacological erection treatment of erectile dysfunction.
    Hattat H; Ozkara H; Akkus E; Alici B
    J Androl; 1994; 15 Suppl():47S-49S. PubMed ID: 7721677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
    Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
    Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental status of topical therapies for erectile and ejaculatory dysfunction.
    Morales A
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S80-5. PubMed ID: 11035392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
    Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE
    Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous use of vasoactive drugs in the diagnosis and treatment of erectile impotence].
    Pastorini S; Marino G; Cocimano V; Marten Perolino R
    Minerva Urol Nefrol; 1992; 44(3):191-3. PubMed ID: 1492270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil.
    Moncada I; Martinez-Salamanca J; Ruiz-Castañe E; Romero J
    Int J Impot Res; 2018 Oct; 30(5):203-208. PubMed ID: 30050072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of erectile dysfunction--the current status].
    Schultheiss D; Stief CG
    Urologe A; 2003 Oct; 42(10):1322-9. PubMed ID: 14569380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sildenafil and alprostadil in the combined drug therapy of erectile dysfunction].
    Mazo EB; Dmitriev DG; Gamidov SI; Ovchinnikov RI
    Urologiia; 2002; (3):39-43. PubMed ID: 12180059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program.
    Steidle C; Padma-Nathan H; Salem S; Tayse N; Thwing D; Fendl J; Yeager J; Harning R
    Urology; 2002 Dec; 60(6):1077-82. PubMed ID: 12475674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
    Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
    Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.
    Padma-Nathan H; Steidle C; Salem S; Tayse N; Yeager J; Harning R
    Int J Impot Res; 2003 Feb; 15(1):10-7. PubMed ID: 12605235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions.
    Renganathan R; Suranjan B; Kurien T
    Spinal Cord; 1997 Feb; 35(2):99-103. PubMed ID: 9044517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients.
    Padma-Nathan H; Yeager JL
    Urology; 2006 Aug; 68(2):386-91. PubMed ID: 16904458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil versus nitroglycerin: a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence.
    Cavallini G
    J Urol; 1991 Jul; 146(1):50-3. PubMed ID: 1905361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.